Fanales-Belasio E, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of Infection: a brief overview. Annali dell’Istituto Superiore Di Sanita. 2010;46(1):5–14.

CAS  PubMed  Google Scholar 

Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV Lancet. 2018;392(10148):685–97.

Article  PubMed  Google Scholar 

Akiyama H, Gummuluru S. HIV-1 persistence and chronic induction of Innate Immune responses in macrophages. Viruses. 2020;12(7).

Zilberman-Schapira G, Zmora N, Itav S, Bashiardes S, Elinav H, Elinav E. The gut microbiome in human immunodeficiency virus Infection. BMC Med. 2016;14(1):83.

Article  PubMed  PubMed Central  Google Scholar 

Anastasi JK, Capili B. HIV-related diarrhea and outcome measures. J Association Nurses AIDS Care: JANAC. 2001;12 Suppl:44–50. quiz 1–4.

CAS  Google Scholar 

Steele AK, Lee EJ, Vestal B, Hecht D, Dong Z, Rapaport E, et al. Contribution of intestinal barrier damage, microbial translocation and HIV-1 Infection status to an inflammaging signature. PLoS ONE. 2014;9(5):e97171.

Article  PubMed  PubMed Central  Google Scholar 

El Kamari V, Sattar A, McComsey GA. Brief Report: Gut Structural Damage: an Ongoing Process in Chronically Untreated HIV Infection. Journal of acquired immune deficiency syndromes (1999). 2019;80(2):242-5.

Tinmouth J, Kandel G, Tomlinson G, Walmsley S, Steinhart HA, Glazier R. Systematic review of strategies to measure HIV-related diarrhea. HIV Clin Trial. 2007;8(3):155–63.

Article  Google Scholar 

Schmidt TSB, Raes J, Bork P. The human gut Microbiome: from Association to Modulation. Cell. 2018;172(6):1198–215.

Article  CAS  PubMed  Google Scholar 

Gomaa EZ. Human gut microbiota/microbiome in health and Diseases: a review. Antonie Van Leeuwenhoek. 2020;113(12):2019–40.

Article  PubMed  Google Scholar 

Kim SK, Guevarra RB, Kim YT, Kwon J, Kim H, Cho JH, et al. Role of Probiotics in Human Gut Microbiome-Associated Diseases. J Microbiol Biotechnol. 2019;29(9):1335–40.

Article  PubMed  Google Scholar 

Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV Disease. Annu Rev Pathol. 2011;6:223–48.

Article  CAS  PubMed  Google Scholar 

Shale M, Schiering C, Powrie F. CD4(+) T-cell subsets in intestinal inflammation. Immunol Rev. 2013;252(1):164–82.

Article  PubMed  PubMed Central  Google Scholar 

Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, et al. Primary HIV-1 Infection is associated with preferential depletion of CD4 + T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004;200(6):761–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martens EC, Neumann M, Desai MS. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol. 2018;16(8):457–70.

Article  CAS  PubMed  Google Scholar 

Desai SN, Landay AL. HIV and aging: role of the microbiome. Curr Opin HIV AIDS. 2018;13(1):22–7.

Article  CAS  PubMed  Google Scholar 

Flygel TT, Sovershaeva E, Claassen-Weitz S, Hjerde E, Mwaikono KS, Odland J, et al. Composition of gut microbiota of children and adolescents with Perinatal Human Immunodeficiency Virus Infection taking antiretroviral therapy in Zimbabwe. J Infect Dis. 2020;221(3):483–92.

CAS  PubMed  Google Scholar 

Pilakka-Kanthikeel PK, Kris A, Selvaraj A, Swaminathan S, Pahwa S. Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting. J Acquir Immune Defic Syndr. 2014;66(1):16–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tincati C, Douek DC, Marchetti G. Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV Infection. AIDS Res Therapy. 2016;13:19.

Article  Google Scholar 

Kelly P, Davies SE, Mandanda B, Veitch A, McPhail G, Zulu I, et al. Enteropathy in zambians with HIV related Diarrhoea: regression modelling of potential determinants of mucosal damage. Gut. 1997;41(6):811–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Z, Peters BA, Usyk M, Xing J, Hanna DB, Wang T et al. Gut microbiota, plasma metabolomic profiles, and carotid artery Atherosclerosis in HIV Infection. Arteriosclerosis, Thrombosis, and vascular biology. 2022;42(8):1081–93.

Ouyang J, Isnard S, Lin J, Fombuena B, Marette A, Routy B, et al. Metformin effect on gut microbiota: insights for HIV-related inflammation. AIDS Res Therapy. 2020;17(1):10.

Article  Google Scholar 

Kang Y, Cai Y. Altered gut microbiota in HIV Infection: future perspective of fecal microbiota transplantation therapy. AIDS Res Hum Retroviruses. 2019;35(3):229–35.

Article  PubMed  Google Scholar 

Zhang F, Aschenbrenner D, Yoo JY, Zuo T. The gut mycobiome in health, Disease, and clinical applications in association with the gut bacterial microbiome assembly. The Lancet Microbe. 2022;3(12):e969–e83.

Article  CAS  PubMed  Google Scholar 

Hiller E, Zavrel M, Hauser N, Sohn K, Burger-Kentischer A, Lemuth K, et al. Adaptation, adhesion and invasion during interaction of Candida albicans with the host–focus on the function of cell wall proteins. Int J Med Microbiology: IJMM. 2011;301(5):384–9.

Article  CAS  Google Scholar 

Koh AY. Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot Cell. 2013;12(11):1416–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Logan C, Beadsworth MB, Beeching NJ. HIV and Diarrhoea: what is new? Current opinion in infectious Diseases. 2016;29(5):486–94.

Vujkovic-Cvijin I, Somsouk M. HIV and the gut microbiota: composition, consequences, and avenues for amelioration. Curr HIV/AIDS Rep. 2019;16(3):204–13.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Y, Ou Z, Tang X, Zhou Y, Xu H, Wang X, et al. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome. J Cell Mol Med. 2018;22(4):2263–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Assimakopoulos SF, Dimitropoulou D, Marangos M, Gogos CA. Intestinal barrier dysfunction in HIV Infection: pathophysiology, clinical implications and potential therapies. Infection. 2014;42(6):951–9.

Article  CAS  PubMed  Google Scholar 

Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, et al. Fungi and inflammatory bowel Diseases: alterations of composition and diversity. Scand J Gastroenterol. 2008;43(7):831–41.

Article  CAS  PubMed  Google Scholar 

Schaller M, Schäfer W, Korting HC, Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol. 1998;29(2):605–15.

Article  CAS  PubMed  Google Scholar 

Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, Soll DR. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous Infection. Infect Immun. 1999;67(12):6652–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schaller M, Bein M, Korting HC, Baur S, Hamm G, Monod M, et al. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun. 2003;71(6):3227–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naglik JR, Moyes D, Makwana J, Kanzaria P, Tsichlaki E, Weindl G, et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiol (Reading). 2008;154(Pt 11):3266–80.

Article  CAS  Google Scholar 

Gropp K, Schild L, Schindler S, Hube B, Zipfel PF, Skerka C. The yeast Candida albicans evades human complement Attack by secretion of aspartic proteases. Mol Immunol. 2009;47(2–3):465–75.

Article  CAS  PubMed  Google Scholar 

Badiee P, Alborzi A, Davarpanah MA, Shakiba E. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iran Med. 2010;13(4):282–7.

CAS  PubMed  Google Scholar 

Hamad I, Abou Abdallah R, Ravaux I, Mokhtari S, Tissot-Dupont H, Michelle C, et al. Metabarcoding analysis of eukaryotic microbiota in the gut of HIV-infected patients. PLoS ONE. 2018;13(1):e0191913.

Article  PubMed  PubMed Central  Google Scholar 

Kretschmar M, Felk A, Staib P, Schaller M, Hess D, Callapina M, et al. Individual acid aspartic proteinases (saps) 1–6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. Microb Pathog. 2002;32(2):61–70.

Article  CAS  PubMed  Google Scholar 

Stehr F, Felk A, Kretschmar M, Schaller M, Schäfer W, Hube B. [Extracellular hydrolytic enzymes and their relevance during Candida albicans Infections]. Mycoses. 2000;43(Suppl 2):17–21.

CAS  PubMed  Google Scholar 

Banjara N, Nickerson KW, Suhr MJ, Hallen-Adams HE. Killer toxin from several food-derived Debaryomyces hansenii strains effective against pathogenic Candida yeasts. Int J Food Microbiol. 2016;222:23–9.